Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Equal-Weight on Ortho Clinical Diagnostic, Raises Price Target to $18.19

Author: Benzinga Newsdesk | May 06, 2022 07:50am
Morgan Stanley maintains Ortho Clinical Diagnostic (NASDAQ:OCDX) with a Equal-Weight and raises the price target from $16.9 to $18.19.

Posted In: OCDX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist